United Therapeutics Soars 28.5% on Drug Patent Ruling
August 29, 2014 at 16:28 PM EDT
United Therapeutics shares soared 28.5 percent on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug.
